Table 4.
HRs for all-cause mortality, cardiovascular mortality, and new-onset CV events among participants in the different risk factor groups
| | Risk factor groups, HR (95% CI)a | p value for trend | ||
|---|---|---|---|---|
| 0 risk factor | 1 risk factor | 2 risk factors | ||
| All-cause mortality (n = 63) | ||||
| Model 1 (unadjusted) | 1 (reference) | 1.91 (1.06–3.44) | 3.28 (1.67–6.44) | 0.001 |
| Model 2b | 1 (reference) | 1.92 (1.06–3.49) | 3.28 (1.65–6.52) | 0.001 |
| Model 3c | 1 (reference) | 1.90 (1.03–3.52) | 3.76 (1.83–7.73) | 0.001 |
| Cardiovascular mortality (n = 36) | ||||
| Model 1 (unadjusted) | 1 (reference) | 2.72 (1.12–6.62) | 7.03 (2.80–17.63) | <0.001 |
| Model 2b | 1 (reference) | 2.95 (1.20–7.20) | 7.70 (3.04–19.5) | <0.001 |
| Model 3c | 1 (reference) | 3.11 (1.23–7.84) | 9.23 (3.42–24.95) | <0.001 |
| CVD events (n = 100) | ||||
| Model 1 (unadjusted) | 1 (reference) | 1.90 (1.18–3.05) | 4.24 (2.52–7.13) | <0.001 |
| Model 2b | 1 (reference) | 1.97 (1.22–3.19) | 4.51 (2.65–7.66) | <0.001 |
| Model 3c | 1 (reference) | 1.68 (1.01–2.76) | 4.21 (2.39–7.21) | <0.001 |
HRs, hazard ratios; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol.
aParticipants were categorized as having 0 risk factor (without PH or HVC); 1 risk factor (with PH or HVC); or 2 risk factors (with PH and HVC).
bModel 2 included adjustment for age and sex.
cModel 3 included the variables in Model 2 and clinical and behavioral characteristics when follow-up time started (previous history of CVD, body mass index, age of initial dialysis, hypertension, diabetes, albumin, LDL-C, TC, TG).